These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 22487008)

  • 1. Role for direct electronic verification of pharmaceutical ingestion in pharmaceutical development.
    DiCarlo LA
    Contemp Clin Trials; 2012 Jul; 33(4):593-600. PubMed ID: 22487008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First experience with a wireless system incorporating physiologic assessments and direct confirmation of digital tablet ingestions in ambulatory patients with schizophrenia or bipolar disorder.
    Kane JM; Perlis RH; DiCarlo LA; Au-Yeung K; Duong J; Petrides G
    J Clin Psychiatry; 2013 Jun; 74(6):e533-40. PubMed ID: 23842023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of effectiveness: how much can we extrapolate from existing studies?
    Lee H; Yim DS; Zhou H; Peck CC
    AAPS J; 2005 Oct; 7(2):E467-74. PubMed ID: 16353924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication compliance as a feature in drug development.
    Kastrissios H; Blaschke TF
    Annu Rev Pharmacol Toxicol; 1997; 37():451-75. PubMed ID: 9131261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine.
    Toutain PL; Lees P
    J Vet Pharmacol Ther; 2004 Dec; 27(6):467-77. PubMed ID: 15601441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of pharmacokinetic-pharmacodynamic relationships in drug development].
    Bellissant E; Courcier-Duplantier S; Blin O;
    Therapie; 2002; 57(4):347-57. PubMed ID: 12422555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic-pharmacodynamic relationships for analgesics.
    Suri A; Estes KS; Geisslinger G; Derendorf H
    Int J Clin Pharmacol Ther; 1997 Aug; 35(8):307-23. PubMed ID: 9266286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating potential benefits of dose-exposure-response modeling for dose finding.
    Hsu CH
    Pharm Stat; 2009; 8(3):203-15. PubMed ID: 19629954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic dosing in children in Europe: can we grade the evidence from pharmacokinetic/pharmacodynamic studies - and when is enough data enough?
    Barker CI; Standing JF; Turner MA; McElnay JC; Sharland M
    Curr Opin Infect Dis; 2012 Jun; 25(3):235-42. PubMed ID: 22517604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of assessing drug concentration exposure in pharmacogenetic and imaging studies.
    Lotrich FE; Bies RR; Smith GS; Pollock BG
    J Psychopharmacol; 2006 Jul; 20(4 Suppl):33-40. PubMed ID: 16785268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic alliance, a stake in schizophrenia].
    Charpentier A; Goudemand M; Thomas P
    Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methods for measuring, enhancing, and accounting for medication adherence in clinical trials.
    Vrijens B; Urquhart J
    Clin Pharmacol Ther; 2014 Jun; 95(6):617-26. PubMed ID: 24739446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early clinical experience with networked system for promoting patient self-management.
    Au-Yeung KY; Moon GD; Robertson TL; Dicarlo LA; Epstein MS; Weis SE; Reves RR; Engel G
    Am J Manag Care; 2011 Jul; 17(7):e277-87. PubMed ID: 21819175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tailor-made drug treatment for children: creation of an infrastructure for data-sharing and population PK-PD modeling.
    Ince I; de Wildt SN; Tibboel D; Danhof M; Knibbe CA
    Drug Discov Today; 2009 Mar; 14(5-6):316-20. PubMed ID: 19059496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics/Pharmacodynamics and the stages of drug development: role of modeling and simulation.
    Chien JY; Friedrich S; Heathman MA; de Alwis DP; Sinha V
    AAPS J; 2005 Oct; 7(3):E544-59. PubMed ID: 16353932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New paradigm in dose-finding trials: patient-specific dosing and beyond phase I.
    Rogatko A; Babb JS; Tighiouart M; Khuri FR; Hudes G
    Clin Cancer Res; 2005 Aug; 11(15):5342-6. PubMed ID: 16061846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personal digital video: a method to monitor drug regimen adherence during human clinical investigations.
    Carroll CC; Trappe TA
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1125-7. PubMed ID: 17184489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementing a low-cost web-based clinical trial management system for community studies: a case study.
    Geyer J; Myers K; Vander Stoep A; McCarty C; Palmer N; DeSalvo A
    Clin Trials; 2011 Oct; 8(5):634-44. PubMed ID: 21813582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories.
    Blaschke TF; Osterberg L; Vrijens B; Urquhart J
    Annu Rev Pharmacol Toxicol; 2012; 52():275-301. PubMed ID: 21942628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.